Sarah Melville
@sarahkmels.bsky.social
Reposted by Sarah Melville
Skin Disorders in Kidney Disease: Core Curriculum 2026 - American Journal of Kidney Diseases ajkd.org/article/S027... Thankful for the opportunity to contribute to this Core Curriculum feature.
🙏
🙏
Skin Disorders in Kidney Disease: Core Curriculum 2026
Skin disorders occur commonly in patients with chronic kidney disease (CKD) and may
greatly impact their quality of life. These skin disorders have varying underlying
pathophysiologies, but there are ...
ajkd.org
November 28, 2025 at 1:30 AM
Skin Disorders in Kidney Disease: Core Curriculum 2026 - American Journal of Kidney Diseases ajkd.org/article/S027... Thankful for the opportunity to contribute to this Core Curriculum feature.
🙏
🙏
November 28, 2025 at 1:02 AM
Reposted by Sarah Melville
November 27, 2025 at 5:00 PM
Reposted by Sarah Melville
Advance care planning: we need to change our approach to improve patient and clinician engagement - Kidney International Reports www.kireports.org/article/S246...
Advance care planning: we need to change our approach to improve patient and clinician engagement
Advance care planning (ACP) is the process of evaluating and defining goals and preferences
for future medical treatment and care. ACP enables these discussions with care partners
and health care prof...
www.kireports.org
November 27, 2025 at 4:52 PM
Advance care planning: we need to change our approach to improve patient and clinician engagement - Kidney International Reports www.kireports.org/article/S246...
Reposted by Sarah Melville
That was quick!
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
November 26, 2025 at 12:21 AM
That was quick!
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA
www.fda.gov/drugs/novel-...
#NephSky
#TopNephrology
Reposted by Sarah Melville
It’s absolutely absurd that American doctors haven’t completely turned on the AMA and this administration.
But not so absurd when you realize German doctors did the exact same thing in 1933. Bad, horrible things incoming.
But not so absurd when you realize German doctors did the exact same thing in 1933. Bad, horrible things incoming.
pmc.ncbi.nlm.nih.gov
November 26, 2025 at 1:22 AM
It’s absolutely absurd that American doctors haven’t completely turned on the AMA and this administration.
But not so absurd when you realize German doctors did the exact same thing in 1933. Bad, horrible things incoming.
But not so absurd when you realize German doctors did the exact same thing in 1933. Bad, horrible things incoming.
Reposted by Sarah Melville
Well deserved Cristina and Brian!
Don't think we won't hound u @hswapnil.medsky.social @kidneyboy.bsky.social ! 😉
Don't think we won't hound u @hswapnil.medsky.social @kidneyboy.bsky.social ! 😉
November 25, 2025 at 12:09 PM
Well deserved Cristina and Brian!
Don't think we won't hound u @hswapnil.medsky.social @kidneyboy.bsky.social ! 😉
Don't think we won't hound u @hswapnil.medsky.social @kidneyboy.bsky.social ! 😉
Reposted by Sarah Melville
What an incredible commitment it’s been, ten years and a whole ecosystem of learning and innovation. Thank you both for your leadership and also that you’ve made sure NephJC will continue to grow in the future.
November 25, 2025 at 12:56 PM
What an incredible commitment it’s been, ten years and a whole ecosystem of learning and innovation. Thank you both for your leadership and also that you’ve made sure NephJC will continue to grow in the future.
Reposted by Sarah Melville
An announcement
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Taking the reigns — NephJC
In April 2014, Swapnil and I launched NephJC—and within weeks we were overwhelmed by the sheer work of running a twice-monthly, Twitter-based journal club. Fortunately, we also had a deep bench of fri...
www.nephjc.com
November 25, 2025 at 12:03 PM
An announcement
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Reposted by Sarah Melville
partly explained by lower transplant rates in women
?maybe higher preponderance of lupus in women with associated badness
What else could be contributing?
#NephSky
?maybe higher preponderance of lupus in women with associated badness
What else could be contributing?
#NephSky
November 25, 2025 at 7:14 PM
partly explained by lower transplant rates in women
?maybe higher preponderance of lupus in women with associated badness
What else could be contributing?
#NephSky
?maybe higher preponderance of lupus in women with associated badness
What else could be contributing?
#NephSky
Reposted by Sarah Melville
I did not know it was this bad
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
November 25, 2025 at 7:14 PM
I did not know it was this bad
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
Look at the mortality in younger females (versus males) in CKD 5
jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta
#NephSky #GenderDisparities
Reposted by Sarah Melville
🚨Kidney Week On-Demand is now available! Explore 250+ hours of presentations and expert insights from #KidneyWk.
💡 Discover new developments shaping kidney care
📚 Learn from expert leaders
⏱️ Watch anytime, anywhere
Get access with your onsite code or purchase now.🔗http://asn.kdny.info/52LT50XxyRX
💡 Discover new developments shaping kidney care
📚 Learn from expert leaders
⏱️ Watch anytime, anywhere
Get access with your onsite code or purchase now.🔗http://asn.kdny.info/52LT50XxyRX
November 25, 2025 at 8:01 PM
🚨Kidney Week On-Demand is now available! Explore 250+ hours of presentations and expert insights from #KidneyWk.
💡 Discover new developments shaping kidney care
📚 Learn from expert leaders
⏱️ Watch anytime, anywhere
Get access with your onsite code or purchase now.🔗http://asn.kdny.info/52LT50XxyRX
💡 Discover new developments shaping kidney care
📚 Learn from expert leaders
⏱️ Watch anytime, anywhere
Get access with your onsite code or purchase now.🔗http://asn.kdny.info/52LT50XxyRX
Reposted by Sarah Melville
Every year, #NephJC celebrates successful, practice-changing trials. ✨ Which trials do you think are deserving for #TopNephrology 2025? #nephsky
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
Top Stories in Nephrology 2024 — NephJC
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every b...
www.nephjc.com
November 20, 2025 at 10:42 PM
Every year, #NephJC celebrates successful, practice-changing trials. ✨ Which trials do you think are deserving for #TopNephrology 2025? #nephsky
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
Reposted by Sarah Melville
🏅 Dr. Tomoko Takano receives the 2025 Medal of Research Excellence from The Kidney Foundation of Canada for advancing kidney research worldwide. @cusm-muhc.bsky.social @healthsciences.mcgill.ca @mcgill.ca
🔗 rimuhc.ca/en/-/dr-tomo...
🔗 rimuhc.ca/en/-/dr-tomo...
November 11, 2025 at 8:15 PM
🏅 Dr. Tomoko Takano receives the 2025 Medal of Research Excellence from The Kidney Foundation of Canada for advancing kidney research worldwide. @cusm-muhc.bsky.social @healthsciences.mcgill.ca @mcgill.ca
🔗 rimuhc.ca/en/-/dr-tomo...
🔗 rimuhc.ca/en/-/dr-tomo...
Reposted by Sarah Melville
Self-Advocacy and Kidney Disease: Finding your Voice
Kidney Foundation of Canada La Fondation canadienne du rein
youtu.be/WRbPv-5MycE
Kidney Foundation of Canada La Fondation canadienne du rein
youtu.be/WRbPv-5MycE
Self-Advocacy and Kidney Disease: Finding your Voice
YouTube video by kidneycanada
youtu.be
August 19, 2025 at 3:52 AM
Self-Advocacy and Kidney Disease: Finding your Voice
Kidney Foundation of Canada La Fondation canadienne du rein
youtu.be/WRbPv-5MycE
Kidney Foundation of Canada La Fondation canadienne du rein
youtu.be/WRbPv-5MycE
Reposted by Sarah Melville
Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss highlights from #KidneyWk.
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
November 22, 2025 at 2:00 PM
Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss highlights from #KidneyWk.
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
➡️ Global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors & fish oil for kidney protection
➡️ Treatment for kidney disease in #diabetes
Listen now: ja.ma/4oVEgEV
Reposted by Sarah Melville
I’m a little shocked at this review of resistant hypertension in CKD.
academic.oup.com/ckj/advance-...
- Weird take on BP targets (there are other trials besides SPRINT)
- Thiazides don’t work in CKD, except chlorthalidone (demonstrably false)
- Don’t use spiro if eGFR <45 because hyperK ?!?!?
1/2
academic.oup.com/ckj/advance-...
- Weird take on BP targets (there are other trials besides SPRINT)
- Thiazides don’t work in CKD, except chlorthalidone (demonstrably false)
- Don’t use spiro if eGFR <45 because hyperK ?!?!?
1/2
2025 Update on resistant hypertension in CKD: where do we stand and where do we go?
Abstract. Resistant hypertension is highly prevalent among individuals with chronic kidney disease (CKD) and is closely associated with accelerated decline
academic.oup.com
November 23, 2025 at 3:40 PM
I’m a little shocked at this review of resistant hypertension in CKD.
academic.oup.com/ckj/advance-...
- Weird take on BP targets (there are other trials besides SPRINT)
- Thiazides don’t work in CKD, except chlorthalidone (demonstrably false)
- Don’t use spiro if eGFR <45 because hyperK ?!?!?
1/2
academic.oup.com/ckj/advance-...
- Weird take on BP targets (there are other trials besides SPRINT)
- Thiazides don’t work in CKD, except chlorthalidone (demonstrably false)
- Don’t use spiro if eGFR <45 because hyperK ?!?!?
1/2
Reposted by Sarah Melville
A few years ago my colleagues and I wanted to do a BMJ Christmas edition article where we found a physician with the initials AI and had them predict stuff. Turns out I is a pretty uncommon surname initial 😢
October 24, 2025 at 10:58 PM
A few years ago my colleagues and I wanted to do a BMJ Christmas edition article where we found a physician with the initials AI and had them predict stuff. Turns out I is a pretty uncommon surname initial 😢
Reposted by Sarah Melville
#CardioSky #MedSky @cardioobdoc.bsky.social @aspcardio.bsky.social @cardioob.bsky.social @ahascience.bsky.social
Are you interested in #BloodPressure?
Please join me & the other invited speakers & moderators for #NHI #NHLBI online 2 Day Workshop!
Free Registration👉
web.cvent.com/event/e7c2bd...
Are you interested in #BloodPressure?
Please join me & the other invited speakers & moderators for #NHI #NHLBI online 2 Day Workshop!
Free Registration👉
web.cvent.com/event/e7c2bd...
November 23, 2025 at 12:45 AM
#CardioSky #MedSky @cardioobdoc.bsky.social @aspcardio.bsky.social @cardioob.bsky.social @ahascience.bsky.social
Are you interested in #BloodPressure?
Please join me & the other invited speakers & moderators for #NHI #NHLBI online 2 Day Workshop!
Free Registration👉
web.cvent.com/event/e7c2bd...
Are you interested in #BloodPressure?
Please join me & the other invited speakers & moderators for #NHI #NHLBI online 2 Day Workshop!
Free Registration👉
web.cvent.com/event/e7c2bd...
More IgAN information this Monday via the @csnscn.bsky.social webinar: www.csncommunity.ca?fbclid=IwdGR...
(free to register), 🤓😃🙏
#nephjc
(free to register), 🤓😃🙏
#nephjc
CSN/SCN COMMUNITY - Registration
www.csncommunity.ca
November 19, 2025 at 3:59 AM
More IgAN information this Monday via the @csnscn.bsky.social webinar: www.csncommunity.ca?fbclid=IwdGR...
(free to register), 🤓😃🙏
#nephjc
(free to register), 🤓😃🙏
#nephjc
Reposted by Sarah Melville
Yes! It can be hard but most folks don't get a lot of symptoms on 0.25 dose. If they go to 0.5 and have issues, go back to 0.25 and go up by "clicks" instead of full dose! See: diabetesjournals.org/care/article...
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens
Glucagon-like peptide 1 receptor agonists (GLP-1RA) have transformed the landscape of type 2 diabetes and chronic weight management (1). Clinical trials ha
diabetesjournals.org
March 6, 2025 at 12:30 PM
Yes! It can be hard but most folks don't get a lot of symptoms on 0.25 dose. If they go to 0.5 and have issues, go back to 0.25 and go up by "clicks" instead of full dose! See: diabetesjournals.org/care/article...
Reposted by Sarah Melville
I love this tradition #NephJC
a man in a suit and tie is saying stay classy .
ALT: a man in a suit and tie is saying stay classy .
media.tenor.com
November 19, 2025 at 3:01 AM
I love this tradition #NephJC
Reposted by Sarah Melville
We likely will have to treat IgA patients differently based on their disease timeline. New, flaring patients need upstream treatment, chronic patients that have damage that can’t be unfibrosed need a different therapy plan. There are plenty of patients for all our therapy options. #nephjc
November 19, 2025 at 2:59 AM
We likely will have to treat IgA patients differently based on their disease timeline. New, flaring patients need upstream treatment, chronic patients that have damage that can’t be unfibrosed need a different therapy plan. There are plenty of patients for all our therapy options. #nephjc